Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 242

    1.

    Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM.

    Diabetes. 2005 Nov;54(11):3140-7.PMID: 16249437 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM; insulin resistance atherosclerosis study.

    Diabetes. 2004 Oct;53(10):2623-32.PMID: 15448093 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.

    Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB Jr, Haffner SM.

    Diabetes Care. 2007 Jul;30(7):1819-27. Epub 2007 Apr 11.PMID: 17429060 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.

    Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Son BH, Shin JH.

    Metabolism. 2006 Dec;55(12):1604-9.PMID: 17142131 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease]

    Liu M, Yan HM, Gao X, Gao J.

    Zhonghua Yi Xue Za Zhi. 2007 Jan 23;87(4):253-5. Chinese. PMID: 17425870 [PubMed - indexed for MEDLINE]Related articles

    6.

    Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.

    Cankurtaran M, Tayfur O, Yavuz BB, Geyik S, Akhan O, Arslan S.

    Acta Gastroenterol Belg. 2007 Jul-Sep;70(3):253-9.PMID: 18074733 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prediction of coronary atherosclerotic disease with liver transaminase level.

    Adibi P, Sadeghi M, Mahsa M, Rozati G, Mohseni M.

    Liver Int. 2007 Sep;27(7):895-900.PMID: 17696927 [PubMed - indexed for MEDLINE]Related articles

    8.

    Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth.

    Oliveira AC, Oliveira AM, Almeida MS, Silva AM, Adan L, Ladeia AM.

    J Pediatr. 2008 Mar;152(3):337-42. Epub 2007 Oct 22.PMID: 18280837 [PubMed - indexed for MEDLINE]Related articles

    9.

    Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome.

    Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, Markiewicz W, Levy Y, Brook GJ, Aronson D.

    Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):193-7. Epub 2004 Oct 21.PMID: 15499043 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

    Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.

    Hepatology. 2008 Sep;48(3):792-8.PMID: 18752331 [PubMed - indexed for MEDLINE]Related articles

    11.

    Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

    Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J; west of Scotland coronary prevention study.

    Diabetes. 2004 Nov;53(11):2855-60.PMID: 15504965 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

    Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1889-95.PMID: 12031978 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: a study of Korean adults.

    Kang YH, Min HG, Kim IJ, Kim YK, Son SM.

    Endocr J. 2008 Dec;55(6):1093-102. Epub 2008 Aug 28.PMID: 18753705 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis.

    Dessein PH, Woodiwiss AJ, Joffe BI, Norton GR.

    BMC Cardiovasc Disord. 2007 Oct 29;7:31.PMID: 17967187 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

    Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, Dall'Aglio E, Dalle Grave R, Morpurgo PS, Tomasi F, Vitacolonna E.

    J Endocrinol Invest. 2005 Apr;28(4):333-9.PMID: 15966506 [PubMed - indexed for MEDLINE]Related articles

    16.

    Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths.

    Kelishadi R, Cook SR, Amra B, Adibi A.

    Atherosclerosis. 2009 Jun;204(2):538-43. Epub 2008 Oct 9.PMID: 19013572 [PubMed - indexed for MEDLINE]Related articles

    17.

    Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.

    Kazumi T, Kawaguchi A, Hirano T, Yoshino G.

    Horm Metab Res. 2006 Feb;38(2):119-24.PMID: 16523413 [PubMed - indexed for MEDLINE]Related articles

    18.

    Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study.

    Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Tanizaki Y, Shikata K, Iida M, Kiyohara Y.

    Obesity (Silver Spring). 2007 Jul;15(7):1841-50.PMID: 17636103 [PubMed - indexed for MEDLINE]Related articles

    19.

    Potential role of interleukin-18 in liver disease associated with insulin resistance.

    López-Bermejo A, Bosch M, Recasens M, Biarnés J, Esteve E, Casamitjana R, Vendrell J, Ricart W, Fernández-Real JM.

    Obes Res. 2005 Nov;13(11):1925-31.PMID: 16339124 [PubMed - indexed for MEDLINE]Related articles

    20.

    Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.

    Chen ZW, Chen LY, Dai HL, Chen JH, Fang LZ.

    J Zhejiang Univ Sci B. 2008 Aug;9(8):616-22.PMID: 18763311 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data